Amsurg Corp Com (AMSG) 67.29 $AMSG Amsurg Rises
Post# of 273322
Posted On: 09/03/2016 9:08:37 AM
Amsurg Corp Com (AMSG) 67.29 $AMSG
Amsurg Rises 2.03% on Heavy Volume: Watch For Potential Pullback
Comtex SmarTrend(R) - Fri Sep 02, 1:14PM CDT
Amsurg (NASDAQ:AMSG) traded in a range yesterday that spanned from a low of $65.35 to a high of $66.90. Yesterday, the shares gained 2.0%, which took the trading range above the 3-day high of $65.57 on volume of 1.3 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
AMSG: 67.29 (+1.89)
AMSURG Corp. to Present at the Baird 2016 Global Healthcare Conference
BusinessWire - Thu Sep 01, 10:00AM CDT
AMSURG Corp. (NASDAQ: AMSG) today announced that its management will participate in the Baird 2016 Global Healthcare Conference on Thursday, September 8, 2016, in New York. In connection with the conference, there will be an on-line simulcast and a replay of the presentation available at the Company's web site starting at 3:10 p.m. Eastern Time / 2:10 p.m. Central Time.
AMSG: 67.29 (+1.89)
Look for Shares of Amsurg to Potentially Pullback after Yesterday's 2.91% Rise
Comtex SmarTrend(R) - Mon Aug 29, 2:12PM CDT
Amsurg (NASDAQ:AMSG) traded in a range yesterday that spanned from a low of $63.81 to a high of $65.58. Yesterday, the shares gained 2.9%, which took the trading range above the 3-day high of $64.68 on volume of 553,000 shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
AMSG: 67.29 (+1.89)
AMSURG Declares Quarterly Preferred Stock Dividend
BusinessWire - Thu Aug 25, 3:30PM CDT
AMSURG Corp. (NASDAQ: AMSG) today announced that its Board of Directors has declared a quarterly dividend of $1.3125 per share in cash for the Company's 5.250% Mandatory Convertible Preferred Stock, Series A-1. The dividend is payable on October 1, 2016, to shareholders of record as of September 15, 2016.
AMSG: 67.29 (+1.89)
Amsurg Falls 1.96% on Heavy Volume: Watch For Potential Rebound
Comtex SmarTrend(R) - Tue Aug 16, 4:43PM CDT
Amsurg (NASDAQ:AMSG) traded in a range yesterday that spanned from a low of $64.80 to a high of $66.23. Yesterday, the shares fell 2.0%, which took the trading range below the 3-day low of $65.89 on volume of 338,000 shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
AMSG: 67.29 (+1.89)
Watch for Amsurg to Potentially Rebound After Falling 1.28% Yesterday
Comtex SmarTrend(R) - Wed Aug 10, 3:00PM CDT
Amsurg (NASDAQ:AMSG) traded in a range yesterday that spanned from a low of $65.80 to a high of $67.00. Yesterday, the shares fell 1.3%, which took the trading range below the 3-day low of $66.98 on volume of 437,000 shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
AMSG: 67.29 (+1.89)
Edgemont Capital Partners Completes Sale of Associated Anesthesiologists of Reno to MEDNAX
BusinessWire - Mon Aug 08, 9:49AM CDT
Edgemont Capital Partners, L.P., a leading independent investment banking firm providing M&A advisory services to healthcare companies, today announced that it acted as exclusive financial advisor to Associated Anesthesiologists of Reno, P.C. ("AAR"
in the sale of the company to MEDNAX, Inc. (NYSE: MD). The transaction closed on August 5, 2016 and was led by Jeff Swearingen, Managing Director, Co-founder of Edgemont, and Head of the Firm's Physician Services Group.
AMSG: 67.29 (+1.89), EVHC: 22.18 (+0.73), TMH: 34.13 (+0.72), MD: 66.57 (+2.09)
AMSURG Announces Consent Solicitation with Respect to 5.625% Senior Notes Due 2022
BusinessWire - Mon Aug 08, 6:00AM CDT
AMSURG Corp. (NASDAQ: AMSG) ("AMSURG" announced today that it has commenced a consent solicitation with respect to its 5.625% Senior Notes due 2022 (CUSIP Nos. 03232 PAD0, 03232 PAC2, and U0018WAB2) (the "Notes".
AMSG: 67.29 (+1.89)
AmSurg (AMSG) Lags Q2 Earnings & Sales; Cuts Sales View
Zacks Equity Research - Zacks Investment Research - Thu Aug 04, 9:28AM CDT
AmSurg (AMSG) ended the second quarter of 2016 on a disappointing note, with quarterly numbers missing the Zacks Consensus Estimate on both fronts.
AMSG: 67.29 (+1.89), BABY: 40.64 (+0.93), MASI: 59.90 (+0.47), CPHD: 34.42 (+0.16)
Amedisys (AMED) Down 5% Despite Q2 Earnings and Revenue Beat
Zacks Equity Research - Zacks Investment Research - Thu Aug 04, 8:15AM CDT
Amedisys Inc. (AMED) reported adjusted earnings from continuing operations of 42 cents per share in the second quarter of 2016.
AMSG: 67.29 (+1.89), AFAM: 36.63 (+0.22), BIOS: 2.64 (+0.07), AMED: 49.49 (+1.39)
AMSURG Announces Second-Quarter Financial Results
BusinessWire - Tue Aug 02, 3:05PM CDT
AMSURG Corp. (NASDAQ: AMSG) today announced financial results for the second quarter and six months ended June 30, 2016. The Company's results for the quarter, compared with the second quarter of 2015, included:
AMSG: 67.29 (+1.89), EVHC: 22.18 (+0.73)
ENVISION HEALTHCARE HOLDINGS, INC. SHAREHOLDER ALERT: Former SEC Attorney Willie Briscoe and Powers Taylor LLP Investigate Sale to AMSURG Corp.
BusinessWire - Fri Jun 24, 1:17PM CDT
Former United States Securities and Exchange Commission attorney Willie Briscoe and the securities litigation firm of Powers Taylor LLP are investigating potential claims against the Board of Directors of Envision Healthcare Holdings, Inc. ("Envision" (NYSE: EVHC) concerning the sale to AMSURG Corp. (NASDAQ: AMSG). Under the terms of the agreement, Envision shareholders will only receive 0.334 AMSURG shares for each share owned. The consideration is valued at approximately $26.21, which is significantly lower than the 52-week high and at least one analyst's estimated value of $36.00 per share.
AMSG: 67.29 (+1.89), EVHC: 22.18 (+0.73)
INVESTOR ALERT: Levi & Korsinsky, Notifies Envision Healthcare Holdings, Inc. Shareholders of an Investigation Regarding the Fairness of the Sale of the Company to AMSURG Corp. -- EVHC
PR Newswire - Thu Jun 23, 12:09PM CDT
The following statement is being issued by Levi & Korsinsky, LLP:
AMSG: 67.29 (+1.89), EVHC: 22.18 (+0.73)
SHAREHOLDER ALERT: Brodsky & Smith, LLC Announces Investigation of The Board of Directors of Envision Healthcare Holdings, Inc. - EVHC
ACCESSWIRE - Wed Jun 22, 8:35PM CDT
BALA CYNWYD, PA / ACCESSWIRE / June 22, 2016 / Law office of Brodsky & Smith, LLC announces that it is investigating potential claims against the Board of Directors of Envision Healthcare Holdings, Inc. ("Envision" or "the Company" (NYSE: EVHC) for possible breaches of fiduciary duty and other violations of state law in connection with the sale of the Company to AmSurg Corp. ("AmSurg".
AMSG: 67.29 (+1.89), EVHC: 22.18 (+0.73)
SHAREHOLDER ALERT: Levi & Korsinsky, Notifies Shareholders of Envision Healthcare Holdings, Inc. of Commencement of an Investigation Regarding the Fairness of the Sale of the Company to AMSURG Corp. -- EVHC
ACCESSWIRE - Tue Jun 21, 5:16PM CDT
NEW YORK, NY / ACCESSWIRE / June 21, 2016 / The following statement is being issued by Levi & Korsinsky, LLP:
AMSG: 67.29 (+1.89), EVHC: 22.18 (+0.73)
ENVISION HEALTHCARE SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Announces the Investigation of Envision Healthcare Holdings, Inc. (EVHC) Over the Proposed Sale of the Company to AmSurg Corp.
PR Newswire - Tue Jun 21, 3:21PM CDT
Nadeem Faruqi, founding partner at Faruqi & Faruqi, LLP, a leading national securities firm headquartered in New York City, is investigating the Board of Directors of Envision Healthcare Holdings, Inc. ("Envision Healthcare" or the "Company" (NYSE:EVHC) for potential breaches of fiduciary duties in connection with the sale of the Company to AmSurg Corp. ("AmSurg" for approximately $4.73 billion.
AMSG: 67.29 (+1.89), EVHC: 22.18 (+0.73)
Envision Healthcare Holdings Inc. Acquisition May Not Be in the Best Interests of EVHC Shareholders
PR Newswire - Mon Jun 20, 10:30AM CDT
WeissLaw LLP is investigating possible breaches of fiduciary duty and other violations of law by the Board of Directors of Envision Healthcare Holdings Inc. ("EVHC" or the "Company" in connection with the Company's proposed plan of merger with AmSurg Corp. ("AmSurg", announced on June 15, 2016. Under the terms of the agreement, EVHC shareholders will receive 0.334 of a share of AmSurg common stock for each EVHC share they own, representing consideration of $25.89 per share.
AMSG: 67.29 (+1.89), EVHC: 22.18 (+0.73)
Ryan & Maniskas, LLP Announces Investigation of Envision Healthcare Holdings, Inc.
PR Newswire - Fri Jun 17, 9:45AM CDT
Ryan & Maniskas, LLP is investigating potential claims against the board of directors of Envision Healthcare Holdings, Inc. ("Envision" or the "Company" (NYSE: EVHC) concerning possible breaches of fiduciary duty and other violations of law related to the Company's efforts to sell the Company to AmSurg Corp. ("AmSurg" in a transaction valued at approximately $4.8 billion.
AMSG: 67.29 (+1.89), EVHC: 22.18 (+0.73)
AmSurg, Envision Healthcare Set to Merge by 2016-End
Zacks Equity Research - Zacks Investment Research - Fri Jun 17, 8:47AM CDT
Envision shareholders will own 53% of the combined entity while AmSurg (AMSG) shareholders will have 47%.
AMSG: 67.29 (+1.89), EVHC: 22.18 (+0.73), BAX: 46.28 (+0.10), LMAT: 18.35 (+0.59)
Amsurg Rises 2.03% on Heavy Volume: Watch For Potential Pullback
Comtex SmarTrend(R) - Fri Sep 02, 1:14PM CDT
Amsurg (NASDAQ:AMSG) traded in a range yesterday that spanned from a low of $65.35 to a high of $66.90. Yesterday, the shares gained 2.0%, which took the trading range above the 3-day high of $65.57 on volume of 1.3 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
AMSG: 67.29 (+1.89)
AMSURG Corp. to Present at the Baird 2016 Global Healthcare Conference
BusinessWire - Thu Sep 01, 10:00AM CDT
AMSURG Corp. (NASDAQ: AMSG) today announced that its management will participate in the Baird 2016 Global Healthcare Conference on Thursday, September 8, 2016, in New York. In connection with the conference, there will be an on-line simulcast and a replay of the presentation available at the Company's web site starting at 3:10 p.m. Eastern Time / 2:10 p.m. Central Time.
AMSG: 67.29 (+1.89)
Look for Shares of Amsurg to Potentially Pullback after Yesterday's 2.91% Rise
Comtex SmarTrend(R) - Mon Aug 29, 2:12PM CDT
Amsurg (NASDAQ:AMSG) traded in a range yesterday that spanned from a low of $63.81 to a high of $65.58. Yesterday, the shares gained 2.9%, which took the trading range above the 3-day high of $64.68 on volume of 553,000 shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
AMSG: 67.29 (+1.89)
AMSURG Declares Quarterly Preferred Stock Dividend
BusinessWire - Thu Aug 25, 3:30PM CDT
AMSURG Corp. (NASDAQ: AMSG) today announced that its Board of Directors has declared a quarterly dividend of $1.3125 per share in cash for the Company's 5.250% Mandatory Convertible Preferred Stock, Series A-1. The dividend is payable on October 1, 2016, to shareholders of record as of September 15, 2016.
AMSG: 67.29 (+1.89)
Amsurg Falls 1.96% on Heavy Volume: Watch For Potential Rebound
Comtex SmarTrend(R) - Tue Aug 16, 4:43PM CDT
Amsurg (NASDAQ:AMSG) traded in a range yesterday that spanned from a low of $64.80 to a high of $66.23. Yesterday, the shares fell 2.0%, which took the trading range below the 3-day low of $65.89 on volume of 338,000 shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
AMSG: 67.29 (+1.89)
Watch for Amsurg to Potentially Rebound After Falling 1.28% Yesterday
Comtex SmarTrend(R) - Wed Aug 10, 3:00PM CDT
Amsurg (NASDAQ:AMSG) traded in a range yesterday that spanned from a low of $65.80 to a high of $67.00. Yesterday, the shares fell 1.3%, which took the trading range below the 3-day low of $66.98 on volume of 437,000 shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
AMSG: 67.29 (+1.89)
Edgemont Capital Partners Completes Sale of Associated Anesthesiologists of Reno to MEDNAX
BusinessWire - Mon Aug 08, 9:49AM CDT
Edgemont Capital Partners, L.P., a leading independent investment banking firm providing M&A advisory services to healthcare companies, today announced that it acted as exclusive financial advisor to Associated Anesthesiologists of Reno, P.C. ("AAR"
in the sale of the company to MEDNAX, Inc. (NYSE: MD). The transaction closed on August 5, 2016 and was led by Jeff Swearingen, Managing Director, Co-founder of Edgemont, and Head of the Firm's Physician Services Group. AMSG: 67.29 (+1.89), EVHC: 22.18 (+0.73), TMH: 34.13 (+0.72), MD: 66.57 (+2.09)
AMSURG Announces Consent Solicitation with Respect to 5.625% Senior Notes Due 2022
BusinessWire - Mon Aug 08, 6:00AM CDT
AMSURG Corp. (NASDAQ: AMSG) ("AMSURG"
announced today that it has commenced a consent solicitation with respect to its 5.625% Senior Notes due 2022 (CUSIP Nos. 03232 PAD0, 03232 PAC2, and U0018WAB2) (the "Notes". AMSG: 67.29 (+1.89)
AmSurg (AMSG) Lags Q2 Earnings & Sales; Cuts Sales View
Zacks Equity Research - Zacks Investment Research - Thu Aug 04, 9:28AM CDT
AmSurg (AMSG) ended the second quarter of 2016 on a disappointing note, with quarterly numbers missing the Zacks Consensus Estimate on both fronts.
AMSG: 67.29 (+1.89), BABY: 40.64 (+0.93), MASI: 59.90 (+0.47), CPHD: 34.42 (+0.16)
Amedisys (AMED) Down 5% Despite Q2 Earnings and Revenue Beat
Zacks Equity Research - Zacks Investment Research - Thu Aug 04, 8:15AM CDT
Amedisys Inc. (AMED) reported adjusted earnings from continuing operations of 42 cents per share in the second quarter of 2016.
AMSG: 67.29 (+1.89), AFAM: 36.63 (+0.22), BIOS: 2.64 (+0.07), AMED: 49.49 (+1.39)
AMSURG Announces Second-Quarter Financial Results
BusinessWire - Tue Aug 02, 3:05PM CDT
AMSURG Corp. (NASDAQ: AMSG) today announced financial results for the second quarter and six months ended June 30, 2016. The Company's results for the quarter, compared with the second quarter of 2015, included:
AMSG: 67.29 (+1.89), EVHC: 22.18 (+0.73)
ENVISION HEALTHCARE HOLDINGS, INC. SHAREHOLDER ALERT: Former SEC Attorney Willie Briscoe and Powers Taylor LLP Investigate Sale to AMSURG Corp.
BusinessWire - Fri Jun 24, 1:17PM CDT
Former United States Securities and Exchange Commission attorney Willie Briscoe and the securities litigation firm of Powers Taylor LLP are investigating potential claims against the Board of Directors of Envision Healthcare Holdings, Inc. ("Envision"
(NYSE: EVHC) concerning the sale to AMSURG Corp. (NASDAQ: AMSG). Under the terms of the agreement, Envision shareholders will only receive 0.334 AMSURG shares for each share owned. The consideration is valued at approximately $26.21, which is significantly lower than the 52-week high and at least one analyst's estimated value of $36.00 per share. AMSG: 67.29 (+1.89), EVHC: 22.18 (+0.73)
INVESTOR ALERT: Levi & Korsinsky, Notifies Envision Healthcare Holdings, Inc. Shareholders of an Investigation Regarding the Fairness of the Sale of the Company to AMSURG Corp. -- EVHC
PR Newswire - Thu Jun 23, 12:09PM CDT
The following statement is being issued by Levi & Korsinsky, LLP:
AMSG: 67.29 (+1.89), EVHC: 22.18 (+0.73)
SHAREHOLDER ALERT: Brodsky & Smith, LLC Announces Investigation of The Board of Directors of Envision Healthcare Holdings, Inc. - EVHC
ACCESSWIRE - Wed Jun 22, 8:35PM CDT
BALA CYNWYD, PA / ACCESSWIRE / June 22, 2016 / Law office of Brodsky & Smith, LLC announces that it is investigating potential claims against the Board of Directors of Envision Healthcare Holdings, Inc. ("Envision" or "the Company"
(NYSE: EVHC) for possible breaches of fiduciary duty and other violations of state law in connection with the sale of the Company to AmSurg Corp. ("AmSurg". AMSG: 67.29 (+1.89), EVHC: 22.18 (+0.73)
SHAREHOLDER ALERT: Levi & Korsinsky, Notifies Shareholders of Envision Healthcare Holdings, Inc. of Commencement of an Investigation Regarding the Fairness of the Sale of the Company to AMSURG Corp. -- EVHC
ACCESSWIRE - Tue Jun 21, 5:16PM CDT
NEW YORK, NY / ACCESSWIRE / June 21, 2016 / The following statement is being issued by Levi & Korsinsky, LLP:
AMSG: 67.29 (+1.89), EVHC: 22.18 (+0.73)
ENVISION HEALTHCARE SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Announces the Investigation of Envision Healthcare Holdings, Inc. (EVHC) Over the Proposed Sale of the Company to AmSurg Corp.
PR Newswire - Tue Jun 21, 3:21PM CDT
Nadeem Faruqi, founding partner at Faruqi & Faruqi, LLP, a leading national securities firm headquartered in New York City, is investigating the Board of Directors of Envision Healthcare Holdings, Inc. ("Envision Healthcare" or the "Company"
(NYSE:EVHC) for potential breaches of fiduciary duties in connection with the sale of the Company to AmSurg Corp. ("AmSurg" for approximately $4.73 billion. AMSG: 67.29 (+1.89), EVHC: 22.18 (+0.73)
Envision Healthcare Holdings Inc. Acquisition May Not Be in the Best Interests of EVHC Shareholders
PR Newswire - Mon Jun 20, 10:30AM CDT
WeissLaw LLP is investigating possible breaches of fiduciary duty and other violations of law by the Board of Directors of Envision Healthcare Holdings Inc. ("EVHC" or the "Company"
in connection with the Company's proposed plan of merger with AmSurg Corp. ("AmSurg", announced on June 15, 2016. Under the terms of the agreement, EVHC shareholders will receive 0.334 of a share of AmSurg common stock for each EVHC share they own, representing consideration of $25.89 per share. AMSG: 67.29 (+1.89), EVHC: 22.18 (+0.73)
Ryan & Maniskas, LLP Announces Investigation of Envision Healthcare Holdings, Inc.
PR Newswire - Fri Jun 17, 9:45AM CDT
Ryan & Maniskas, LLP is investigating potential claims against the board of directors of Envision Healthcare Holdings, Inc. ("Envision" or the "Company"
(NYSE: EVHC) concerning possible breaches of fiduciary duty and other violations of law related to the Company's efforts to sell the Company to AmSurg Corp. ("AmSurg" in a transaction valued at approximately $4.8 billion. AMSG: 67.29 (+1.89), EVHC: 22.18 (+0.73)
AmSurg, Envision Healthcare Set to Merge by 2016-End
Zacks Equity Research - Zacks Investment Research - Fri Jun 17, 8:47AM CDT
Envision shareholders will own 53% of the combined entity while AmSurg (AMSG) shareholders will have 47%.
AMSG: 67.29 (+1.89), EVHC: 22.18 (+0.73), BAX: 46.28 (+0.10), LMAT: 18.35 (+0.59)
(0)
(0)